分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Assay establishment and validation of a high-throughput organoid-based drug screening platform

Li Xiaomeng, Fu Guoxiang, Zhang Long, Guan Ruoyu, Tang Peiyuan, Zhang Jialing, Rao Xinxin, Chen Shengzhi, Xu Xiaoya, Zhou Yi, Deng Yun, Lv Tao, He Xingfeng, Mo Shaobo, Mu Peiyuan, Gao Jianjun, Hua Gu

Journal:Stem Cell Research & Therapy

IF:8.08

DOI:10.1186/s13287-022-02902-3

PMID:35619149

Published:2022-05-26

research field:

Abstract

Background Organoids are three-dimensional structures that closely recapitulate tissue architecture and cellular composition, thereby holding great promise for organoid-based drug screening. Although growing in three-dimensional provides the possibility for organoids to recapitulate main features of corresponding tissues, it makes it incommodious for imaging organoids in two-dimensional and identifying surviving organoids from surrounding dead cells after organoids being treated by irradiation or chemotherapy. Therefore, significant work remains to establish high-quality controls to standardize organoid analyses and make organoid models more reproducible. Methods In this study, the Z-stack imaging technique was used for the imaging of three-dimensional organoids to gather all the organoids’ maximum cross sections in one imaging. The combination of live cell staining fluorescent dye Calcein-AM and ImageJ assessment was used to analyze the survival of organoids treated by irradiation or chemotherapy. Results We have established a novel quantitative high-throughput imaging assay that harnesses the scalability of organoid cultures. Using this assay, we can capture organoid growth over time, measure multiple whole-well organoid readouts, and show the different responses to drug treatments. Conclusions In summary, combining the Z-stack imaging technique and fluorescent labeling methods, we established an assay for the imaging and analysis of three-dimensional organoids. Our data demonstrated the feasibility of using organoid-based platforms for high-throughput drug screening assays. Graphical Abstract

本文使用的Yeasen产品

购物车
客服
转染试用